Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)

NCT00525668 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: epigallocatechin-gallate (Sunphenon)
DRUG: placebo

Sponsor

Charite University, Berlin, Germany